Trial intelligence / Profile preview

Postcoital test in clomiphene-responsive WHO class II anovulatory women

NL-OMON36839Active, not recruiting

Sponsor
Medisch Spectrum Twente
Start
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of clomiphene in anovulation (2 arms), sponsored by Medisch Spectrum Twente. Primary endpoint: Pregnancy rates by postcoital test result within 6 months. Started Jun 2009; status: active, not recruiting.

02

Drugs

clomiphene
03

Conditions

anovulation

Beyond the preview

Go deeper on NL-OMON36839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call